These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27116333)

  • 21. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Cancer Stem Cells: Promises and Challenges.
    Kuhlmann JD; Hein L; Kurth I; Wimberger P; Dubrovska A
    Anticancer Agents Med Chem; 2016; 16(1):38-58. PubMed ID: 26179271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cell and its niche in malignant progression of oral potentially malignant disorders.
    Surendran S; Siddappa G; Mohan A; Hicks W; Jayaprakash V; Mimikos C; Mahri M; Almarzouki F; Morrell K; Ravi R; Govindan S; Sushma CN; Raghavan N; Birur P; Ilayaraja J; Merzianu M; Reid M; Suresh A; Kuriakose MA
    Oral Oncol; 2017 Dec; 75():140-147. PubMed ID: 29224811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Getting to the source: selective drug targeting of cancer stem cells.
    Ismail F; Winkler DA
    ChemMedChem; 2014 May; 9(5):885-98. PubMed ID: 24760779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of miR-92a promotes the tumor growth of osteosarcoma by suppressing F-box and WD repeat-containing protein 7.
    Jiang X; Li X; Wu F; Gao H; Wang G; Zheng H; Wang H; Li J; Chen C
    Gene; 2017 Mar; 606():10-16. PubMed ID: 28069547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. F-box proteins in cancer stemness: An emerging prognostic and therapeutic target.
    Khan AQ; Al-Tamimi M; Uddin S; Steinhoff M
    Drug Discov Today; 2021 Dec; 26(12):2905-2914. PubMed ID: 34265459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
    Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
    Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
    Kitagawa K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?
    Sánchez-García I; Vicente-Dueñas C; Cobaleda C
    Bioessays; 2007 Dec; 29(12):1269-80. PubMed ID: 18022789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cells: the development of new cancer therapeutics.
    Scatena R; Bottoni P; Pontoglio A; Giardina B
    Expert Opin Biol Ther; 2011 Jul; 11(7):875-92. PubMed ID: 21463158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.
    Cao J; Ge MH; Ling ZQ
    Medicine (Baltimore); 2016 Feb; 95(7):e2496. PubMed ID: 26886596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mTORC1 signaling governs hematopoietic stem cell quiescence.
    Gan B; DePinho RA
    Cell Cycle; 2009 Apr; 8(7):1003-6. PubMed ID: 19270523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cells as a target population for drug discovery.
    Bouvard C; Barefield C; Zhu S
    Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.
    Balic A; Sørensen MD; Trabulo SM; Sainz B; Cioffi M; Vieira CR; Miranda-Lorenzo I; Hidalgo M; Kleeff J; Erkan M; Heeschen C
    Mol Cancer Ther; 2014 Jul; 13(7):1758-71. PubMed ID: 24785258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem cells - A therapeutic target?
    Maitland NJ; Collins AT
    Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Stem Cells: Basic Concepts and Therapeutic Implications.
    Nassar D; Blanpain C
    Annu Rev Pathol; 2016 May; 11():47-76. PubMed ID: 27193450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.
    Zhao Y; Dong Q; Li J; Zhang K; Qin J; Zhao J; Sun Q; Wang Z; Wartmann T; Jauch KW; Nelson PJ; Qin L; Bruns C
    Semin Cancer Biol; 2018 Dec; 53():139-155. PubMed ID: 30081228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer.
    Wang X; Cao Y; Zhang S; Chen Z; Fan L; Shen X; Zhou S; Chen D
    Oncotarget; 2017 May; 8(22):36149-36160. PubMed ID: 28193907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.